U.S Domestic
Available Domestic
Lab Tested
Axiolabs Sermorelin 5 mg GHRH Vial for Pituitary Research
Injection · 5mg · vial
Axiolabs Sermorelin is a GHRH analog, the 1-29 fragment that tells the pituitary to release its own growth hormone in a pulse. Supplied as a powder in a 5 mg vial for reconstitution.
GMP-manufactured, HPLC-verified per batch with the COA on file. Sermorelin for sale with international shipping; the product page shows current availability.
Product overview
Axiolabs Sermorelin 5 mg Research Vial
Axiolabs Sermorelin is a GHRH analog, the 1-29 fragment of growth hormone releasing hormone, supplied as a research powder in a 5 mg vial. It acts on the pituitary GHRH receptor, asking the gland to release its own growth hormone in a pulse. Historically the same fragment was the active part of Geref, an injectable that has been discontinued; the material on this page is a research vial, not that medicine, and a ghrelin-receptor peptide such as Ipamorelin is the usual partner in the same order.
- 5 mg of sermorelin per vial
- Lyophilized research powder - needs a solvent
- GMP-manufactured - HPLC-verified per batch, COA on file
- International shipping with discreet plain packaging
How Sermorelin Works
The fragment binds the GHRH receptor on pituitary cells and raises growth hormone output for a short window. Its activity is very brief: for the parent GHRH(1-29) amide a half-life of 6.2 minutes was measured after intravenous dosing in rats, vendor texts quote 10 to 20 minutes, and no human half-life is established. That is why research designs use daily injections instead of weekly ones. A longer-acting analog such as CJC-1295 no DAC is a comparison arm, not a duplicate.
Reconstitution & Storage
Add bacteriostatic water down the side of the vial and swirl gently, never shake: 1 to 2 mL on a 5 mg vial gives 2.5 to 5 mg/mL, so 1 mg is 0.2 to 0.4 mL of solution. Keep the sealed powder cold, dry and out of light, let it reach room temperature before opening, then hold the dissolved solution at 2-8 C and do not freeze it. Vendor reviews pair this short fragment with the stabilised analog Tesamorelin to compare duration.
Quality & Authenticity
Each batch is produced under GMP conditions and verified by third-party HPLC, with a Certificate of Analysis held for the batch. International orders leave in discreet plain packaging, and the product page shows current stock, which at the time of writing is out of stock.
For laboratory research only. Consult a healthcare professional before handling any peptide.
Specifications
| Trade Name | Sermorelin |
| Generic Name | Sermorelin (GHRH 1-29) |
| Manufacturer | Axiolabs |
| Dosage | 5 mg per vial |
| Package | Single vial, research powder |
| Drug Class | GHRH analog peptide, research |
| Administration | Research use after reconstitution |
| Storage | Powder cold and dry; solution 2-8 C, do not freeze |
| Prescription Status | Research use only; not for human use |
| Verification | Third-party HPLC per batch, COA on file |
| Shipping | International 4-10 days |
Stacks
For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.
FAQ
Before you ask
Questions, answered
Sermorelin is the 1-29 fragment of growth hormone releasing hormone, a GHRH analog that binds the pituitary GHRH receptor and prompts the release of the body's own growth hormone. Historically the same fragment was the active part of Geref, a prescription injectable that has since been discontinued. The vial on this page is a research material, and no regulator has approved it for human use.
It is very short. For the parent GHRH(1-29) amide, a half-life of 6.2 minutes was measured after intravenous dosing in rats, and vendor texts quote 10 to 20 minutes for the fragment. No human half-life has been established in the sources checked, so treat any single number for people as an estimate rather than a measured value. Daily injection is the practical result of that short activity.
Add bacteriostatic water down the side of the vial and swirl it gently instead of shaking. One to two millilitres on a 5 mg vial gives 2.5 to 5 mg/mL. Vendor references for the GHRH class mention a daily research amount in the hundreds of micrograms, but that is a vendor figure and not a validated human dose. Keep the solution at 2-8 C, do not freeze it, and open the powder only after it reaches room temperature.
There is no validated human safety profile for the research vial. For the GH peptide class the effects most often described are injection site reactions, edema and fluid retention, joint and muscle aches, flushing and headache, and fatigue. Data on long combinations of a GHRH analog with a ghrelin agonist are thin, so a design that stacks the two receptors is not backed by much human safety information.
Yes. Sermorelin is named directly in class S2 of the WADA Prohibited List, the growth hormone releasing factors section, and it is banned at all times, in and out of competition. The listing names the substance rather than covering it only as a general category. Anyone subject to testing should treat the peptide as prohibited without exception.
The 5 mg vial is listed on this page and the product page shows current availability and price; at the time of writing the vial is out of stock, so check the listing for restocking rather than expecting same day dispatch. International shipping is about 45 dollars, with orders handled in one to two business days and transit of four to ten days. Each batch is GMP-manufactured and HPLC-verified with the COA on file.
Be the first to share your experience with Axiolabs Sermorelin 5 mg GHRH Vial for Pituitary Research
Log in to write a reviewComplete the cycle